Physician profile
Harry Ching
NPI 1720405004
$3,606.49
in general payments reported to CMS, 2019-2025
15 companies · $2,338 in 2025
The $2,338 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.56 · 2021: $148 · 2022: $296 · 2023: $310 · 2024: $499 · 2025: $2,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542 · Consulting Fee: $1,450 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,541.75 |
| Consulting Fee | $1,450.00 |
| Education | $155.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,450.00 | 2025 | Tavneos |
| Regeneron Healthcare Solutions, INC. | $384.92 | 2022-2025 | Dupixent |
| Stryker Corporation | $329.34 | 2019-2024 | Xpress Loprofile, Vsp System, Vsp Cranial, Na |
| Integra Lifesciences Corporation | $214.52 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Medtronic, INC. | $211.01 | 2023-2025 | Sinuva, Propel, Nim Vital |
| Optinose US, INC. | $209.06 | 2021-2022 | |
| Glaxosmithkline, LLC. | $186.38 | 2022-2025 | Nucala |
| Aerin Medical INC. | $154.55 | 2022-2025 | |
| Horizon Therapeutics Plc | $121.81 | 2022 | |
| Bausch & Lomb Americas INC. | $112.63 | 2024 | Xiidra, Miebo |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| Genzyme Corporation | $77.64 | 2023-2025 | |
| Intersect Ent, INC. | $25.73 | 2022 | |
| Smith+Nephew, INC. | $15.90 | 2021 | |
| Olympus America INC. | $14.01 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Ching listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.